Joseph, Naima T, and Ai -Ris Y Collier. 2023. “COVID-19 Therapeutics and Considerations for Pregnancy.”. Obstetrics and Gynecology Clinics of North America 50 (1): 163-82.
Abstract
The COVID-19 pandemic has generated an unprecedented amount of novel and repurposed vaccines and therapeutics that have been rapidly developed and implemented into clinical use. Unfortunately, pregnant persons have been excluded from most phase III clinical studies; therefore, our understanding regarding their safety for use in this population stems from understanding of theoretic risks and observational data. In this review, the authors discuss pregnancy-specific considerations for COVID-19 therapeutics.